(Z)-N-Biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxy-acrylamide

ID: ALA142996

Max Phase: Preclinical

Molecular Formula: C19H16N2O2

Molecular Weight: 304.35

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  N#C/C(C(=O)Nc1ccc(-c2ccccc2)cc1)=C(/O)C1CC1

Standard InChI:  InChI=1S/C19H16N2O2/c20-12-17(18(22)15-6-7-15)19(23)21-16-10-8-14(9-11-16)13-4-2-1-3-5-13/h1-5,8-11,15,22H,6-7H2,(H,21,23)/b18-17-

Standard InChI Key:  CAGGGMPTWTUYHZ-ZCXUNETKSA-N

Molfile:  

     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   -0.5218   -3.9354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3468   -3.9354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9343   -3.2209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9343   -2.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6488   -1.9834    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199   -1.9834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946   -2.3959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2091   -2.8084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199   -1.1584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9343   -0.7459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946   -0.7459    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946    0.0791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2091    0.4916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2091    1.3166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199    0.4916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199    1.3166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946    1.7291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946    2.5541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2091    2.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2091    3.7916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4946    4.2041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199    3.7916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2199    2.9666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  3  1  0
  4  3  1  0
  4  5  1  0
  6  4  2  0
  7  6  1  0
  9  6  1  0
  7  8  3  0
  9 10  2  0
  9 11  1  0
 12 11  1  0
 13 12  2  0
 15 12  1  0
 13 14  1  0
 14 17  2  0
 15 16  2  0
 16 17  1  0
 18 17  1  0
 19 18  2  0
 23 18  1  0
 20 19  1  0
 21 20  2  0
 21 22  1  0
 22 23  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA142996

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 304.35

Molecular Weight (Monoisotopic): 304.1212

AlogP: 4.04

#Rotatable Bonds: 4

Polar Surface Area: 73.12

Molecular Species: ACID

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 6.01

CX Basic pKa: ┄

CX LogP: 3.33

CX LogD: 1.93

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.51

Np Likeness Score: -1.12

References

1. Kuo EA, Hambleton PT, Kay DP, Evans PL, Matharu SS, Little E, McDowall N, Jones CB, Hedgecock CJ, Yea CM, Chan AW, Hairsine PW, Ager IR, Tully WR, Williamson RA, Westwood R..  (1996)  Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds.,  39  (23): [PMID:8917650] [10.1021/jm9604437]

2. Davies M, Heikkilä T, McConkey GA, Fishwick CW, Parsons MR, Johnson AP..  (2009)  Structure-based design, synthesis, and characterization of inhibitors of human and Plasmodium falciparum dihydroorotate dehydrogenases.,  52  (9): [PMID:19351152] [10.1021/jm800963t]

Source

Source(1):

• Scientific Literature